Skip to main content
Mereo BioPharma Group plc logo

Mereo BioPharma Group plc — Investor Relations & Filings

Ticker · MREO ISIN · GB00BZ4G2K23 LEI · 213800U8JQHIJOS5AS09 US Manufacturing
Open in API
Filings indexed 635 across all filing types
Latest filing 2020-02-25 Major Shareholding Noti…
Country GB United Kingdom
Listing US MREO

About Mereo BioPharma Group plc

https://www.mereobiopharma.com/

Mereo BioPharma Group plc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for rare diseases with limited or no treatment options. The company's strategy involves acquiring and advancing promising clinical-stage product candidates that have been de-prioritized by larger pharmaceutical or biotechnology companies. This capital-efficient model allows it to develop a specialized pipeline. Its two lead programs are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for Alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). Mereo BioPharma also engages in strategic partnerships and out-licenses other clinical assets to deliver impactful treatments to patients.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. It explicitly details a change in share ownership by Invesco Ltd. in Mereo Biopharma Group PLC, crossing a reporting threshold. This is a classic regulatory disclosure regarding major shareholding notifications, which corresponds to the MRQ category.
2020-02-25 English
6-K
Director's Dealing Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, Mereo Biopharma Group PLC, with the SEC. It includes a notification of director and other PDMR (persons discharging managerial responsibilities) dealings as an exhibit. The content primarily reports insider transactions by company directors or executives. The document length is short (1433 characters), and it is a regulatory filing reporting insider share transactions. Therefore, it fits the category of Director's Dealing (DIRS).
2020-02-21 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is a regulatory requirement for disclosing significant changes in share ownership (crossing thresholds). The text explicitly identifies the issuer (Mereo BioPharma Group plc) and the person subject to the notification (Link Fund Solutions Ltd), detailing the percentage of voting rights held. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2020-02-21 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Mereo BioPharma Group plc. It details a change in share ownership by Invesco Ltd., crossing a reporting threshold. This is a classic regulatory disclosure regarding significant shareholding changes, which falls under the 'Major Shareholding Notification' category.
2020-02-21 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Second Price Monitoring Extension' for Mereo BioPharma Group plc. It is a technical market announcement regarding trading parameters rather than a financial report, management update, or corporate action. As it does not fit into specific categories like dividends, share issues, or earnings, it falls under the general regulatory filing category.
2020-02-20 English
Price Monitoring Extension
Regulatory Filings Classification · 100% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Price Monitoring Extension' for a specific security. It does not contain financial statements, management reports, or corporate governance disclosures. As it is a standard regulatory notification regarding trading parameters that does not fit into the specific categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2020-02-20 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.